Amanda Pedersen

News Editor at Medical Device and Diagnostic Industry (MDDI)

MD+DI Senior Editor. I have covered medtech news for 17 years. My 5-year plan is to get to level 50 on Pokémon Go. All opinions expressed here are my own.

Featured in: Favicon

mddionline.com

linkedin.com Favicon

newsbreak.com Favicon

designnews.com Favicon

plasticstoday.com Favicon

packagingdigest.com Favicon

powderbulksolids.com Favicon

batterytechonline.com Favicon

ourcommunitynow.com Favicon

thomsonreuters.com + 2 more

Articles

RadNet to Acquire iCad to Boost Cancer Screening Leadership

1 week ago | mddionline.com | Amanda Pedersen

After the market closed Tuesday, Los Angeles, CA-based RadNet announced its plans to acquire Nashua, NH-based iCad in an all-stock transaction. iCad stockholders will receive 0.0677 shares of RadNet common stock for each share of iCad common stock they hold at the closing of the merger.
How J&J Is Navigating Tariffs and Investing in US Manufacturing

1 week ago | mddionline.com | Amanda Pedersen

As expected, tariffs were top of mind for medtech analysts covering Johnson & Johnson's first-quarter earnings call Tuesday morning. CEO Joaquin Duato reminded call participants that in March, J&J announced its commitment to invest more than $55 billion in the US over the next four years in manufacturing, R&D, and technology. "This represents a 25% increase in investment compared to the previous four years," Duato said.
FDA Green-Lights Next Phase of Carmat's Artificial Heart Study

1 week ago | mddionline.com | Amanda Pedersen

Paris, France-based Carmat is now a beat closer to bringing its total artificial heart to the U.S. market. FDA gave Carmat conditional approval to initiate the second cohort of its early feasibility study with the Aeson artificial heart in the United States. The company has been developing the device for years, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure.
Winners, Losers, and Those Caught in Between

1 week ago | mddionline.com | Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006. Amanda's weekly op-ed, Pedersen's POV, was a 2023 Neal Award Winner for "Best Commentary." Pedersen's POV was also a 2024 Neal Awards finalist for "Best Commentary."Amanda Pedersen poses with her Jesse H.
Former Medtronic CEO Criticizes RFK Jr.’s HHS Leadership

2 weeks ago | packagingdigest.com | Amanda Pedersen

Hilary Marston considered it a privilege to serve as FDA’s chief medical officer. But now, thanks to a dramatic restructuring across the Department of Health and Human Services (HHS) that will reduce the agency’s headcount from 82,000 to 62,000, Marston is among the thousands of HHS employees now searching for their “what’s next.”“In this role, I’ve had the joy of working with some of the smartest, most dedicated colleagues within my office, throughout the agency, and across the U.S. government.
Top Medtech Companies for Career Growth

2 weeks ago | mddionline.com | Amanda Pedersen

Today, LinkedIn published its ninth annual Top Companies list, highlighting the 50 best workplaces to grow your career in the United States. LinkedIn said the list is entirely based on its data, and the methodology evaluates companies on various elements of career progression, such as how employees are upskilling, getting promoted, and more. The best part? All of the companies on the list are hiring. Here's a quick look at the medtech companies that made this year's list.
Medtronic's MiniMed 780G Leads in Time in Target Range for Type 1 Diabetes

2 weeks ago | mddionline.com | Amanda Pedersen

A new meta-analysis ranks the efficacy of hybrid closed-loop systems for managing type 1 diabetes. At a GlanceThe study ranked hybrid closed-loop systems made by Medtronic, Tandem Diabetes, CamDiab, DBLG-1 Diabeloop, and Insulet. A total of 28 trials, all enrolling people with type 1 diabetes, were included in the meta-analysis.
Medtech Caught in the Crossfire of Trump's Trade War

2 weeks ago | mddionline.com | Amanda Pedersen

It was refreshing to finally see a statement from AdvaMed's Scott Whitaker last week regarding President Trump's latest tariff policy, but it still feels, to me, like the statement lacked the conviction that I know the organization's president and CEO is capable of. Think back to the 2.3% tax on U.S. medical device revenue that was originally part of the Affordable Care Act.
Tariffs Will Hold Back the US Medtech Industry

3 weeks ago | mddionline.com | Amanda Pedersen

Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.
Former Medtronic CEO Criticizes RFK Jr.'s HHS Leadership

3 weeks ago | mddionline.com | Amanda Pedersen

Hilary Marston considered it a privilege to serve as FDA’s chief medical officer. But now, thanks to a dramatic restructuring across the Department of Health and Human Services (HHS) that will reduce the agency’s headcount from 82,000 to 62,000, Marston is among the thousands of HHS employees now searching for their “what’s next.”“In this role, I’ve had the joy of working with some of the smartest, most dedicated colleagues within my office, throughout the agency, and across the U.S. government.